Parathyroid hormone protects against periodontitis-associated bone loss

Journal of Dental Research

Volumn 82, Issue 10, 2003, Pages 791-795

  Barros, S P ^a   Silva, M A D ^a   Somerman, M J ^b,c   Nociti Jr , F H ^a,b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Anabolism; Parathyroid hormone; Periodontitis

Indexed keywords

PARATHYROID HORMONE; PLACEBO;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; COMPARATIVE STUDY; DRUG EFFECT; GINGIVA; IMAGE PROCESSING; LEUKOCYTE COUNT; MALE; MONONUCLEAR CELL; NEUTROPHIL; OSTEOLYSIS; PATHOLOGY; PERIODONTITIS; RANDOMIZATION; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; WISTAR RAT;

ALVEOLAR BONE LOSS; ANALYSIS OF VARIANCE; ANIMALS; GINGIVA; IMAGE PROCESSING, COMPUTER-ASSISTED; INJECTIONS, SUBCUTANEOUS; LEUKOCYTE COUNT; LEUKOCYTES, MONONUCLEAR; MALE; NEUTROPHILS; PARATHYROID HORMONE; PERIODONTITIS; PLACEBOS; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 0242335939     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910308201006     Document Type: Article

References (30)

1. Burgering BM, Pronk GJ, van Weeren PC, Chardin P, Bos JL (1993). cAMP antagonizes p21 ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor. EMBO J 12:4211-4220.
2. Canalis E, Centrella M, Burch W, McCarthy TL (1989). Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone on bone cell cultures. J Clin Invest 63:60-65.
3. Chen HL, Demiralp B, Schneider A, Koh AJ, Silve C, Wang CY, et al. (2002). Parathyroid hormone and parathyroid hormone-related protein exert both pro- and anti-apoptotic effects in mesenchymal cells. J Biol Chem 277:19374-19381.
4. Chiang CY, Kyritsis G, Graves DT, Amar S (1999). Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide. Infect Immun 67:4231-4236.
5. Civitelli R, Ziambaras K, Warlow PM, Lecanda F, Nelson T, Harley J, et al. (1998). Regulation of connexin 43 expression and function by prostaglandin E2 (PGE2) and parathyroid hormone (PTH) in osteoblastic cells. J Cell Biochem 68:8-21.
6. Cornish J, Callon KE, Lin C, Xiao C, Moseley JM, Reid IR (1999). Stimulation of osteoblast proliferation by C-terminal fragments of parathyroid hormone-related protein. J Bone Miner Res 14:915-922.
7. Doherty CC, LaBelle P, Collins JF, Brautbar N, Massry SG (1988). Effect of parathyroid hormone on random migration of human polymorphonuclear leukocytes. Am J Nephrol 8:212-219.
8. El-Shinnawi UM, El-Tantawy SI (2003). The effect of alendronate sodium on alveolar bone loss in periodontitis (clinical trial). J Int Acad Periodontol 5:5-10.
9. Fletcher JM, Nair SP, Ward JM, Henderson B, Wilson M (2001). Analysis of the effect of changing environmental conditions on the expression patterns of exported surface-associated proteins of the oral pathogen Actinobacillus actinomycetemcomitans. Microb Pathog 30:359-368.
10. Goltzman D (1999). Interactions of PTH and PTHrP with the PTH/PTHrP receptor and downstream signaling pathways: exceptions that provide the rules. J Bone Miner Res 14:173-177.
11. Hagino H, Okano T, Akhter MP, Enokida M, Teshima R (2001). Effect of parathyroid hormone on cortical bone response to in vivo external loading of the rat tibia. J Bone Miner Metab 19:244-250.
12. Horwitz MJ, Tedesco MB, Gundberg C, Garcia-Ocana A, Stewart AF (2003). Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab 88:569-575.
13. Iida-Klein A, Zhou H, Lu SS, Levine LR, Ducayen-Knowles M, Dempster DW, et al. (2002). Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice. J Bone Miner Res 17:808-816.
14. Jiang Y, Mehta CK, Hsu TY, Alsulaimani FF (2002). Bacteria induced osteoclastogenesis via an osteoblast-independent pathway. Infect Immun 70:3143-3148.
15. Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC (1999). Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 104:439-446.
16. Jouishomme H, Whitfield JF, Gagnon L, Maclean S, Isaacs R, Chakravarthy B, et al. (1994). Further definition of the protein kinase C activation domain of the parathyroid hormone. J Bone Miner Res 9:943-949.
17. Kondo A, Koshihara Y, Togari A (2001). Signal transduction system for interleukin-6 synthesis stimulated by lipopolysaccharide in human osteoblasts. J Interferon Cytokine Res 21:943-950.
18. Linkhart TA, Mohan S (1989). Parathyroid hormone stimulates release of insulin-like growth factor-I (IGF-I) and IGF-II from neonatal mouse calvaria in organ culture. Endocrinology 125:1484-1491.
19. Martin TJ, Ng KW (1994). Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity. J Cell Biochem 56:357-366.
20. McCauley LK, Rosol TJ, Merryman JI, Capen CC (1992). Parathyroid hormone-related protein binding to human T-cell lymphotropic virus type I-infected lymphocytes. Endocrinology 130:300-306.
21. Morley P, Whitfield JF, Willick GE (1997). Anabolic effects of PTH on bone. Trends Endocrinol Metab 8:225-231.
22. Nagasawa T, Kobayashi H, Kiji M, Aramaki M, Mahanonda R, Kojima T, et al. (2002). LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin. Clin Exp Immunol 130:338-344.
23. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, et al. (2001). Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434-1441.
24. Rovin S, Costich ER, Gordon HA (1966). The influence of bacteria and irritation in the initiation of periodontal disease in germfree and conventional rats. J Periodontal Res 1:193-204.
25. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, et al. (1997). Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309-319.
26. Spurney RF, Flannery PJ, Garner SC, Athirakul K, Liu S, Guilak F, et al. (2002). Anabolic effect of a G protein-coupled receptor kinase inhibitor expressed in osteoblasts. J Clin Invest 109:1361-137.
27. Swarthout JT, Doggett TA, Lemker JL, Partridge NC (2001). Stimulation of extracellular signal-regulated kinases and proliferation in rat osteoblastic cells by parathyroid hormone is protein kinase C-dependent. J Biol Chem 276:7586-7592.
28. Swarthout JT, D'Alonzo RC, Selvamurugan N, Partridge NC (2002). Parathyroid hormone-dependent signaling pathways regulating genes in bone cells. Gene 282:1-17.
29. Teng YT, Nguyen H, Gao X, Kong YY, Gorczynski RM, Singh B, et al. (2000). Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest 106:R59-R67.
30. Zou W, Bar-Shavit Z (2002). Dual modulation of osteoclast differentiation by lipopolysaccharide. J Bone Miner Res 17:1211-1218.